Alfasigma brings to the Russian market a new probiotic Enterolaktis

At the end of August, 2023 company Alfasigma organized the action devoted to health of intestines and a microbiota. The producer presented still new to many doctors and consumers of a probiotics Enterolaktis (dietary supplement, is not medicine) on the basis of Lacticaseibacillus paracasei DG strain. Enterolaktis appeared in a portfolio of Alfasigma which is the expert in the field of studying of a microbiota and productions of products, influencing intestines health, after acquisition of the Italian companies Sofar. By data Iqvia Holdings, Inc for 2022, product hold leading position in the market of probiotics to Italy...